Insmed Inc (INSM) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Insmed Inc

NASDAQ | INSM

73.47

USD

+0.0318 (+0.04%)

AT CLOSE (AS OF Apr 3, 2025)

$13B

MARKET CAP

P/E Ratio

-5.57

EPS

$85

52 Week High

$22

52 Week Low

LIFE SCIENCES

Sector

INSM Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

INSM Technicals

Tags:

INSM Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	-$194M
Total Revenue	$224M
Cost Of Revenue	$418M
Costof Goods And Services Sold	$66M
Operating Income	-$710M
Selling General And Administrative	$345M
Research And Development	$571M
Operating Expenses	$923M
Investment Income Net	-
Net Interest Income	-$82M
Interest Income	$1.9M
Interest Expense	$82M
Non Interest Income	$305M
Other Non Operating Income	$1.9M
Depreciation	$5.5M
Depreciation And Amortization	$7.8M
Income Before Tax	-$747M
Income Tax Expense	$2.6M
Interest And Debt Expense	$82M
Net Income From Continuing Operations	-$750M
Comprehensive Income Net Of Tax	-$751M
Ebit	-$665M
Ebitda	-$658M
Net Income	-$750M

Revenue & Profitability

Earnings Performance

INSM Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$1.3B
Total Current Assets	$929M
Cash And Cash Equivalents At Carrying Value	$482M
Cash And Short Term Investments	$780M
Inventory	$83M
Current Net Receivables	$41M
Total Non Current Assets	$304M
Property Plant Equipment	$65M
Accumulated Depreciation Amortization Ppe	$45M
Intangible Assets	$200M
Intangible Assets Excluding Goodwill	$64M
Goodwill	$136M
Investments	$596M
Long Term Investments	-
Short Term Investments	$298M
Other Current Assets	$24M
Other Non Current Assets	-
Total Liabilities	$1.7B
Total Current Liabilities	$226M
Current Accounts Payable	$65M
Deferred Revenue	-
Current Debt	$2.6M
Short Term Debt	$11M
Total Non Current Liabilities	$1.3B
Capital Lease Obligations	$27M
Long Term Debt	$1.2B
Current Long Term Debt	$0
Long Term Debt Noncurrent	$1.2B
Short Long Term Debt Total	$1.2B
Other Current Liabilities	$150M
Other Non Current Liabilities	$3.1M
Total Shareholder Equity	-$332M
Treasury Stock	-
Retained Earnings	-$3.4B
Common Stock	$1.5M
Common Stock Shares Outstanding	$148M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (USD)
Operating Cashflow	-$536M
Payments For Operating Activities	$47M
Proceeds From Operating Activities	-
Change In Operating Liabilities	$15M
Change In Operating Assets	$43M
Depreciation Depletion And Amortization	$5.5M
Capital Expenditures	$13M
Change In Receivables	$12M
Change In Inventory	$14M
Profit Loss	-$750M
Cashflow From Investment	-$224M
Cashflow From Financing	$168M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	$152M
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$171M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$750M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	-$194M
Total Revenue	$224M
Cost Of Revenue	$418M
Costof Goods And Services Sold	$66M
Operating Income	-$710M
Selling General And Administrative	$345M
Research And Development	$571M
Operating Expenses	$923M
Investment Income Net	-
Net Interest Income	-$82M
Interest Income	$1.9M
Interest Expense	$82M
Non Interest Income	$305M
Other Non Operating Income	$1.9M
Depreciation	$5.5M
Depreciation And Amortization	$7.8M
Income Before Tax	-$747M
Income Tax Expense	$2.6M
Interest And Debt Expense	$82M
Net Income From Continuing Operations	-$750M
Comprehensive Income Net Of Tax	-$751M
Ebit	-$665M
Ebitda	-$658M
Net Income	-$750M

INSM Profile

Insmed Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	13.04%	-	706,860,781
NVDA	$103.14	-6.59%	$2.68T	263,349,217
LCID	$2.34	-2.30%	$7.67B	187,389,814
F	$9.68	-4.68%	$39.53B	173,285,336
PTIX	$0.43	91.50%	$4.04M	173,208,693

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.76	1.92%	$399.61B	6,083,153
ABBV	$202.45	-1.34%	$364.89B	5,252,004
NVO	$67.60	-0.95%	$308.32B	7,033,051
AZN	$74.03	2.50%	$225.70B	6,150,517

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$6.06	1,818.33%	$26.40M	302,396
MKTW	$9.19	1,684.81%	$19.91M	117,875
ICCT	$4.38	111.59%	$9.78M	168,784,937
PTIX	$0.43	91.50%	$4.04M	173,208,693
MRM	$0.65	74.84%	$2.91M	51,693,935

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	20,249,631
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669